CATAFLAM
Generic Name for CATAFLAM
Diclofenac potassium 50mg; tabs.
Legal Classification:
Rx
Pharmacological Class for CATAFLAM
NSAID (benzeneacetic acid deriv.).
Manufacturer of CATAFLAM
Novartis Pharmaceuticals Corp
|
Indications for CATAFLAM
Osteoarthritis. Rheumatoid arthritis. Ankylosing spondylitis.
Adult dose for CATAFLAM
Osteoarthritis: 50mg 2–3 times daily. Rheumatoid arthritis: 50mg 3–4 times daily. Ankylosing spondylitis: 25mg 4 times daily, may add 25mg at bedtime.
Children's dosing for CATAFLAM
Not recommended.
Contraindications for CATAFLAM
Aspirin allergy. Late pregnancy. Coronary artery bypass graft surgery.
Warnings/Precautions for CATAFLAM
Advanced renal disease: not recommended. Peptic ulcer. GI bleeding. Monitor AST/ALT within 4 weeks and then periodically; also blood, hepatic, and renal function in chronic use. Edema. Cardiac failure. Hypertension. Hepatic porphyria. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers: not recommended.
Interactions for CATAFLAM
Digoxin, methotrexate, cyclosporine, lithium toxicity. Antagonizes diuretics. May increase serum potassium level with K+-sparing diuretics. Avoid aspirin. Monitor oral anticoagulants, insulin and sulfonylureas. Increased risk of GI bleed with alcohol.
Adverse Reactions for CATAFLAM
Peptic ulcer, GI bleeding, elevated AST/ALT, abdominal discomfort, constipation, diarrhea, indigestion, nausea, abdominal distention, headache, dizziness, fluid retention, rash (discontinue if occurs), pruritus, tinnitus. See literature re: risk of cardiovascular events.
How is CATAFLAM supplied?
Tabs—100
Related Disease:
Ankylosing spondylitis
Arthritis~NSAIDs
Rheumatoid arthritis